vs
Side-by-side financial comparison of EXPONENT INC (EXPO) and PEOPLES BANCORP INC (PEBO). Click either name above to swap in a different company.
EXPONENT INC is the larger business by last-quarter revenue ($166.3M vs $118.7M, roughly 1.4× PEOPLES BANCORP INC). PEOPLES BANCORP INC runs the higher net margin — 24.4% vs 17.8%, a 6.7% gap on every dollar of revenue. Over the past eight quarters, EXPONENT INC's revenue compounded faster (8.8% CAGR vs 3.7%).
Exponent, Inc. is an American engineering and scientific consulting firm. Exponent has a team of scientists, physicians, engineers, and business consultants which performs research and analysis in more than 90 technical disciplines. The company operates 20 offices in the United States and five offices overseas.
U.S. Bancorp is an American multinational banking institution headquartered in Minneapolis, Minnesota and incorporated in Delaware. It is the 5th-largest bank in the United States as of 2025. As the largest bank in the Midwestern United States, it is considered systemically important by the Financial Stability Board. It is the parent company of its primary operating entity, U.S. Bank National Association, which does business as U.S. Bank. The company provides banking, investment, mortgage, tr...
EXPO vs PEBO — Head-to-Head
Income Statement — Q1 FY2027 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $166.3M | $118.7M |
| Net Profit | $29.6M | $29.0M |
| Gross Margin | — | — |
| Operating Margin | 24.9% | — |
| Net Margin | 17.8% | 24.4% |
| Revenue YoY | 14.3% | — |
| Net Profit YoY | 11.0% | -8.7% |
| EPS (diluted) | $0.59 | $0.81 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $166.3M | $118.7M | ||
| Q4 25 | $147.1M | $117.3M | ||
| Q3 25 | $142.0M | $115.2M | ||
| Q2 25 | $145.5M | $114.5M | ||
| Q1 25 | $136.8M | $112.4M | ||
| Q4 24 | — | $111.6M | ||
| Q3 24 | $136.3M | $113.7M | ||
| Q2 24 | $140.5M | $110.3M |
| Q1 26 | $29.6M | $29.0M | ||
| Q4 25 | $28.0M | $31.8M | ||
| Q3 25 | $26.6M | $29.5M | ||
| Q2 25 | $26.6M | $21.2M | ||
| Q1 25 | $23.6M | $24.3M | ||
| Q4 24 | — | $26.9M | ||
| Q3 24 | $26.0M | $31.7M | ||
| Q2 24 | $29.2M | $29.0M |
| Q1 26 | 24.9% | — | ||
| Q4 25 | 19.7% | 32.4% | ||
| Q3 25 | 12.1% | 33.0% | ||
| Q2 25 | 30.5% | 24.0% | ||
| Q1 25 | 19.9% | 27.9% | ||
| Q4 24 | — | 31.2% | ||
| Q3 24 | 19.0% | 36.0% | ||
| Q2 24 | 25.4% | 32.5% |
| Q1 26 | 17.8% | 24.4% | ||
| Q4 25 | 19.1% | 27.1% | ||
| Q3 25 | 18.7% | 25.6% | ||
| Q2 25 | 18.3% | 18.5% | ||
| Q1 25 | 17.2% | 21.7% | ||
| Q4 24 | — | 24.1% | ||
| Q3 24 | 19.1% | 27.9% | ||
| Q2 24 | 20.8% | 26.3% |
| Q1 26 | $0.59 | $0.81 | ||
| Q4 25 | $0.55 | $0.89 | ||
| Q3 25 | $0.52 | $0.83 | ||
| Q2 25 | $0.52 | $0.59 | ||
| Q1 25 | $0.45 | $0.68 | ||
| Q4 24 | — | $0.76 | ||
| Q3 24 | $0.50 | $0.89 | ||
| Q2 24 | $0.57 | $0.82 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $118.6M | $82.9M |
| Total DebtLower is stronger | — | $691.3M |
| Stockholders' EquityBook value | $338.3M | $1.2B |
| Total Assets | $687.4M | $9.6B |
| Debt / EquityLower = less leverage | — | 0.57× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $118.6M | $82.9M | ||
| Q4 25 | $207.4M | $189.0M | ||
| Q3 25 | $231.8M | $190.2M | ||
| Q2 25 | $245.1M | $186.1M | ||
| Q1 25 | $258.9M | $187.0M | ||
| Q4 24 | — | $217.7M | ||
| Q3 24 | $219.7M | $283.7M | ||
| Q2 24 | $203.3M | $235.9M |
| Q1 26 | — | $691.3M | ||
| Q4 25 | — | $204.1M | ||
| Q3 25 | — | $227.3M | ||
| Q2 25 | — | $232.4M | ||
| Q1 25 | — | $237.0M | ||
| Q4 24 | — | $238.1M | ||
| Q3 24 | — | $236.8M | ||
| Q2 24 | — | $234.3M |
| Q1 26 | $338.3M | $1.2B | ||
| Q4 25 | $402.9M | $1.2B | ||
| Q3 25 | $427.8M | $1.2B | ||
| Q2 25 | $441.4M | $1.2B | ||
| Q1 25 | $421.1M | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | $410.3M | $1.1B | ||
| Q2 24 | $393.2M | $1.1B |
| Q1 26 | $687.4M | $9.6B | ||
| Q4 25 | $761.4M | $9.6B | ||
| Q3 25 | $759.4M | $9.6B | ||
| Q2 25 | $763.2M | $9.5B | ||
| Q1 25 | $777.3M | $9.2B | ||
| Q4 24 | — | $9.3B | ||
| Q3 24 | $744.1M | $9.1B | ||
| Q2 24 | $709.2M | $9.2B |
| Q1 26 | — | 0.57× | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.20× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.22× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EXPO
| Revenues before reimbursements | $151.8M | 91% |
| Reimbursements | $14.5M | 9% |
PEBO
| Net Interest Income | $90.4M | 76% |
| Noninterest Income | $28.3M | 24% |
